AstraZeneca
About AstraZeneca
AstraZeneca is a Healthcare company founded in 2013, and was acquired by Gruenenthal Group in July 2024. Prescription medicine for treating constipation caused by opioid pain medicines. Its website movantik.com draws about 12 thousand monthly visits. Its focus areas include Pharmaceutical Product Websites. Its legal entity is Valinor Pharma, LLC.
Company details
MOVANTIK is a prescription medicine for treating constipation caused by opioid pain medicines in adults with long-lasting chronic non-cancer pain. It works by reducing constipation without causing opioid withdrawal symptoms.
- Stage Acquired
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website movantik.com
- Acquired by Gruenenthal Group (Jul 2024)
- Legal Name Valinor Pharma, Llc
- Investors
- Acquired byGruenenthal Group
(Jul 2024)
Investors in AstraZeneca
AstraZeneca has secured backing from 1 investor. Prominent investors backing the company include Gruenenthal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty biopharmaceutical products are developed internationally by Gruenenthal Group. | 1946 | grunenthal.com | Aachen, Germany |
Investor details for AstraZeneca
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AstraZeneca
2 dated milestones of AstraZeneca across 11 years, from founding to its latest funding, stage changes and deals.
- Founded AstraZeneca is founded.
- Exit Acquired by Gruenenthal Group.
Web traffic of AstraZeneca
The website of AstraZeneca (movantik.com) receives about 11.6K visits a month and ranks #3,543,591 among all websites worldwide, #3,980 in Pharmacy.
- Monthly visits11.6K
▲ 131.5% vs previous month
- Unique visitors2.5K
per month
- Global rank#3,543,591
among all websites
- Category rank#3,980
Health · Pharmacy
- Bounce rate39%
- Pages per visit2.0
- Average visit24 sec
- DevicesDesktop 34% · Mobile 66%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AstraZeneca
AstraZeneca was founded in 2013.
MOVANTIK is a prescription medicine for treating constipation caused by opioid pain medicines in adults with long-lasting chronic non-cancer pain. It works by reducing constipation without causing opioid withdrawal symptoms.
AstraZeneca has 1 investor. Key investors include Gruenenthal Group.
AstraZeneca operates through Valinor Pharma, Llc.
Yes. AstraZeneca was acquired by Gruenenthal Group in July 2024.